戻る
Prenetics Global Ltd (PRE)価格
PRE 株価推移チャート
PRE 収入
Prenetics Global Ltd
$19.24
8.63%
$1.52
終値： Feb 06, 16:00:00 GMT-5
$19.24
0%
$0
アフターマーケット：Feb 06, 20:00:00 GMT-5
最新の利益結果: Q3 '25
報告済み: 2025-11-10
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
PREの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Prenetics Global Ltd PREの前四半期の収益はどうでしたか？
Prenetics Global Ltdの収益見積もりはいくらですか？
Prenetics Global Ltdの収益品質スコアはどれくらいですか？
Prenetics Global Ltdはいつ収益を報告しますか？
Prenetics Global Ltdの予想収益はいくらですか？
Prenetics Global Ltdは収益予想を上回りましたか？
主要データ
前終値
$17.71
始値
$17.5
当日レンジ
$17 - $19.44
52週レンジ
$3.09 - $20.89
取引高
191.4K
平均取引高
179.9K
1株当たり利益(TTM)
-3.45
配当利回り
--
時価総額
$271.4M
PREとは何ですか？
Prenetics Global Ltd. is a health sciences company, which engages in providing consumer health products and services. The company employs 285 full-time employees The company went IPO on 2021-07-06. The firm operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The firm's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The firm is also engaged in consumer health products by a new health and wellness brand IM8.